Literature DB >> 21771581

SDH mutations in cancer.

Chiara Bardella1, Patrick J Pollard, Ian Tomlinson.   

Abstract

The SDHA, SDHB, SDHC, SDHD genes encode the four subunits of succinate dehydrogenase (SDH; mitochondrial complex II), a mitochondrial enzyme involved in two essential energy-producing metabolic processes of the cell, the Krebs cycle and the electron transport chain. Germline loss-of-function mutations in any of the SDH genes or assembly factor (SDHAF2) cause hereditary paraganglioma/phaeochromocytoma syndrome (HPGL/PCC) through a mechanism which is largely unknown. Owing to the central function of SDH in cellular energy metabolism it is important to understand its role in tumor suppression. Here is reported an overview of genetics, clinical and molecular progress recently performed in understanding the basis of HPGL/PCC tumorigenesis. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771581     DOI: 10.1016/j.bbabio.2011.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  134 in total

Review 1.  Alterations of metabolic genes and metabolites in cancer.

Authors:  Eric K Oermann; Jing Wu; Kun-Liang Guan; Yue Xiong
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

Review 2.  Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies.

Authors:  Kristofor A Olson; John C Schell; Jared Rutter
Journal:  Trends Biochem Sci       Date:  2016-02-10       Impact factor: 13.807

3.  Comparative analysis of some aspects of mitochondrial metabolism in differentiated and undifferentiated neuroblastoma cells.

Authors:  Aleksandr Klepinin; Vladimir Chekulayev; Natalja Timohhina; Igor Shevchuk; Kersti Tepp; Andrus Kaldma; Andre Koit; Valdur Saks; Tuuli Kaambre
Journal:  J Bioenerg Biomembr       Date:  2013-09-27       Impact factor: 2.945

4.  Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty.

Authors:  Margarita Raygada; Kathryn S King; Karen T Adams; Constantine A Stratakis; Karel Pacak
Journal:  J Pediatr Endocrinol Metab       Date:  2014-09       Impact factor: 1.634

5.  The LYR factors SDHAF1 and SDHAF3 mediate maturation of the iron-sulfur subunit of succinate dehydrogenase.

Authors:  Un Na; Wendou Yu; James Cox; Daniel K Bricker; Knut Brockmann; Jared Rutter; Carl S Thummel; Dennis R Winge
Journal:  Cell Metab       Date:  2014-06-19       Impact factor: 27.287

Review 6.  Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome.

Authors:  Nikolaos Settas; Fabio R Faucz; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2017-07-21       Impact factor: 4.102

7.  Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia.

Authors:  Zachary J Reitman; Christopher G Duncan; Ethan Poteet; Ali Winters; Liang-Jun Yan; David M Gooden; Ivan Spasojevic; Laszlo G Boros; Shao-Hua Yang; Hai Yan
Journal:  J Biol Chem       Date:  2014-07-01       Impact factor: 5.157

Review 8.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

Review 9.  Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets.

Authors:  Jamie D Weyandt; Craig B Thompson; Amato J Giaccia; W Kimryn Rathmell
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 10.  Targeting mitochondria in cancer: current concepts and immunotherapy approaches.

Authors:  Sergey Pustylnikov; Francesca Costabile; Silvia Beghi; Andrea Facciabene
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.